
<div id="chart">	
    <div id="chart-1"></div>
    <div id="chart-2"></div>
    <div id="chart-3"></div>
    <div id="chart-a"></div>
    <div id="chart-b"></div>
</div>
<div id="text"></div>
<div id="title">SPARK: LABA-LAMA fixed-dose combination is not superior
to SPIRIVA monotherapy in reducing exacerbation rate
(key secondary objective)<sup>1</sup></div>
<div id="title2">ANNUALISED RATE OF MODERATE OR SEVERE COPD EXACERBATIONS
BY TREATMENT GROUP IN SEVERE TO VERY SEVERE COPD PATIENTS<sup>1</sup></div>
<div id="lit-logo"></div>
<div id="study-design-text"></div>	
<div id="study-design-button"></div>

<div id="text2">
	<p><sup>†</sup>Rate reduction 0.90 (95% CI 0.79-1.02), p=0.096.</p>
    <p><sup>‡</sup>Rate reduction 0.88 (95% CI 0.77-0.99), p=0.038.</p>
    <p>NS = not significant</p>
</div>